[1] 中华医学会心血管病学分会, 中国心肌炎心肌病协作组. 中国扩张型心肌病诊断和治疗指南[J]. 临床心血管病杂志, 2018, 34(5):421-434.
[2] 黄妹丹, 何凤珍, 张倬华, 等. 扩张型心肌病常见致病基因及其致病机制的研究进展[J]. 中国临床新医学, 2018, 11(10):1052-1056.
[3] Singh RM, Waqar T, Howarth FC, et al. Hyperglycemia-induced cardiac contractile dysfunction in the diabetic heart[J]. Heart Fail Rev, 2018, 23(1):37-54.
[4] Dhalla NS, Dent MR, Tappia PS, et al. Subcellular remodeling as a viable target for the treatment of congestive heart failure[J]. J Cardiovasc Pharmacol Ther, 2006, 11(1):31-45.
[5] Hu L, Ding M, Tang D, et al. Targeting mitochondrial dynamics by regulating Mfn2 for therapeutic intervention in diabetic cardiomyopathy[J]. Theranostics, 2019, 9(13):3687-3706.
[6] Govindaraj P, Rani B, Sundaravadivel P, et al. Mitochondrial genome variations in idiopathic dilated cardiomyopathy[J]. Mitochondrion, 2019, 48:51-59.
[7] 于瀛, 李毅刚. 闰盘处蛋白质的相互作用以及相关心脏疾病[J]. 复旦学报(医学版), 2016, 43(2):241-243.
[8] Tao S, Chen L, Song J, et al. Tanshinone ⅡA ameliorates diabetic cardiomyopathy by inhibiting Grp78 and CHOP expression in STZ-induced diabetes rats[J]. Exp Ther Med, 2019, 18(1):729-734.
[9] West G, Gullmets J, Virtanen L, et al. Deleterious assembly of the lamin A/C mutant p.S143P causes ER stress in familial dilated cardiomyopathy[J]. J Cell Sci, 2016, 129(14):2732-2743.
[10] 陈芳, 邹联洪, 刘协红, 等. NRF2减轻阿霉素诱导的心肌H9C2细胞氧化应激和溶酶体功能障碍[J]. 中国病理生理杂志, 2019, 35(8):1359-1364.
[11] 刘丹. 全氟辛烷磺酸抑制自噬——溶酶体通路致小鼠ES细胞衍生心肌细胞损伤的机制研究[D]. 杭州:浙江大学, 2019.
[12] 李盛村, 王婷, 王国祥. 心肌中t-tubule重构与治疗新策略[J]. 生理科学进展, 2014, 45(6):468-471.
[13] 王世强, 杨华乾. 心肌细胞兴奋收缩耦联的分子机制[J]. 中国科学:生命科学, 2013, 43(10):833-841.